Product Images Ontralfy

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Ontralfy NDC 82919-626 by Fidelity Biopharma Co., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - ontralfy 01

Chemical Structure - ontralfy 01

Figure 1 - ontralfy 02

Figure 1 - ontralfy 02

The text mentions the "Improvement in Ashworth Score" with a dosage of "16 mg tizanidine" over a period of time represented in hours post-dose. This may refer to a study or information related to the use of tizanidine for assessing muscle spasticity.*

Figure 2 - ontralfy 03

Figure 2 - ontralfy 03

PRINCIPAL DISPLAY PANEL - 473 mL Bottle Label - ontralfy 04

PRINCIPAL DISPLAY PANEL - 473 mL Bottle Label - ontralfy 04

This text provides information about a medication called Ontralfy™. It is an oral solution of tizanidine with a concentration of 2 mg per 5 mL. The solution comes in a 16 fl.oz. bottle and should be stored between 20°C to 25°C. It is important to keep this medication out of reach of children. The manufacturing company is Fidelity BioPharma Co. located in New Haven, CT. For further details about the dosage and usage, refer to the Prescribing Information.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.